Product Categories
Country: | China |
---|---|
Tel: | 400-400-8210725 |
Mobile: | 17717813675 |
E-mail: | |
QQ: | |
Skype: | Chat Now! |
Product Name | MF | CAS | Details |
---|
1-[4-(trifluoromethyl)phenyl]cyclopropan-1-amine hydrochloride | C10H11ClF3N | 1228880-06-5 | Details |
4-Methylisoquinoline-5-sulfonyl chloride | C10H8ClNO2S | 194032-16-1 | Details |
4-(Furan-2-yl)benzaldehyde | C11H8O2 | 60456-77-1 | Details |
4,5-Dimethyl-1H-imidazole-2-thiol | C5H8N2S | 1192-72-9 | Details |
2-Bromo-5-methylpyridine-3-carbaldehyde | C7H6BrNO | 1227577-73-2 | Details |
2-Amino-2-(4-iodophenyl)acetic acid | C8H8INO2 | 299167-68-3 | Details |
(3-((Methylamino)methyl)phenyl)boronic acid | C8H12BNO2 | 1146614-39-2 | Details |
[4-[5-(Methylamino)-1,3,4-thiadiazol-2-yl]phenyl]boronic acid | C9H10BN3O2S | 957034-49-0 | Details |
N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluoro-2-hydroxyphenyl)cyclopropane-1,1-dicarboxamide (Cabozantinib Impurity) | C28H24FN3O6 | 1628530-38-0 | Details |
(4-Bromo-2-chloro-5-methoxyphenyl)boronic acid | C7H7BBrClO3 | 850567-94-1 | Details |
2-(3-Bromo-5-ethoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C14H20BBrO3 | 1073339-03-3 | Details |
(4-(Benzyloxy)-3-chloro-5-methoxyphenyl)boronic acid | C14H14BClO4 | 1218790-59-0 | Details |
(4-((Methylsulfonyl)oxy)phenyl)boronic acid | C7H9BO5S | 957035-04-0 | Details |
4-Hydroxydibenzothiophene | C12H8OS | 24444-75-5 | Details |
3-Bromo-2-fluoro-5-methylphenol | C7H6BrFO | 1026796-51-9 | Details |
3-Chloro-5-(trifluoromethyl)anisole | C8H6ClF3O | 886497-07-0 | Details |
1-Bromo-3-chloro-2-iodo-5-(trifluoromethyl)benzene | C7H2BrClF3I | 175205-55-7 | Details |
1-Methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole | C15H20BNO2 | 596819-10-2 | Details |
4-Nitro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile | C13H15BN2O4 | 1218791-28-6 | Details |
6-cyclopropyl-10-fluorobenzo[k]phenanthridine (Pitavastatin Impurity) | C20H14FN | 1187966-95-5 | Details |
4-Chloro-4'-methoxy-1,1'-biphenyl | C13H11ClO | 58970-19-7 | Details |
2-Bromo-1,4-dichloro-3-fluorobenzene | C6H2BrCl2F | 1373233-32-9 | Details |
2-(5-Chloro-2-methyl-4-(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C14H17BClF3O2 | 1073353-97-5 | Details |
bis(5-(((3S,4R)-4-(4-fluorophenyl)piperidin-3-yl)methoxy)benzo[d][1,3]dioxol-4-yl)methane (Paroxetine Impurity) | C39H40F2N2O6 | 1292846-10-6 | Details |
3,3-Difluorocyclopentan-1-amine | C5H9F2N | 939525-61-8 | Details |
5-Chloro-2,3-dihydro-1H-indene-1-carboxylic acid | C10H9ClO2 | 66041-26-7 | Details |
3-Azabicyclo[3.2.1]octan-8-one | C7H11NO | 240401-35-8 | Details |
2-{Imidazo[1,2-a]pyridin-5-yl}acetic acid | C9H8N2O2 | 175143-91-6 | Details |
2-(Quinolin-8-yl)acetic acid | C11H9NO2 | 152150-04-4 | Details |
Benzyl 2-amino-3-(benzyloxy)propanoate hydrochloride | C17H19NO3 | 21948-10-7 | Details |
Oxane-2-carbaldehyde | C6H10O2 | 19611-45-1 | Details |
5-methoxy-1-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole (Tenofovir Impurity) | C18H23N6O5P | 1234081-04-9 | Details |
Methyl 3-nitro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate | C14H18BNO6 | 957065-97-3 | Details |
tert-Butyl (3S)-3-bromopiperidine-1-carboxylate | C10H18BrNO2 | 1354017-20-1 | Details |
6-(4-((4-carboxybutyl)amino)phenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid (Apixaban Impurity) | C25H26N4O6 | 2264018-89-3 | Details |
(R)-2-Amino-1-(2,2-dimethyl-4H-benzo[d][1,3]dioxin-6-yl)ethan-1-ol (Vilanterol Impurity) | C12H17NO3 | 208925-08-0 | Details |
(E)- 4-(Methylamino)-2-butenoic Acid (Afatinib Impurity) | C5H9NO2 | 69169-63-7 | Details |
4-((R)-3-aminopiperidin-1-yl)-2-((6-((R)-3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile (Trelagliptin Impurity) | C23H31N7O2 | 1917324-14-1 | Details |
sodium (3R,5S)-5-(3-(2-cyclopropyl-4-(4-fluorophenyl)-1-oxidoquinolin-3-yl)oxiran-2-yl)-3,5-dihydroxypentanoate (Pitavastatin Impurity) | C25H24FNO6 | 1980814-90-1 | Details |
2-(1-Methylpiperidin-4-yl)acetic acid hydrochloride | C8H15NO2.ClH | 67686-06-0 | Details |
(2r)-1-Aminopyrrolidine-2-carboxylic acid | C5H10N2O2 | 10139-05-6 | Details |
5-(2-ethoxy-5-(piperazine-1-carbonothioyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidine-7(6H)-thione (Sildenafil Impurity) | C22H28N6OS2 | 1610830-81-3 | Details |
1-(2-Chloroethyl)-4-methylpiperazine | C7H15ClN2 | 39123-20-1 | Details |
4-Amino-1-methyl-1H-pyrazole-5-carboxylic acid | C5H7N3O2 | 790164-97-5 | Details |
(R)-(4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)phosphoramidic acid (Sitagliptin Impurity) | C16H16F6N5O4P | 1351498-25-3 | Details |
1-tert-Butyl 3-ethyl (3r,4s)-4-aminopyrrolidine-1,3-dicarboxylate hydrochloride | C12H23ClN2O4 | 1262849-90-0 | Details |
N-((3R,4S)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (Tofacitinib Impurity) | C27H31N5O2S | 1092578-44-3 | Details |
Methyl 1H-pyrrolo[2,3-c]pyridine-2-carboxylate | C9H8N2O2 | 501892-49-5 | Details |
2-(4-((2-chlorophenyl)(3-chlorophenyl)methyl)piperazin-1-yl)ethanol dihydrochloride (Cetirizine Impurity) | C19H24Cl4N2O | 126517-38-2 | Details |
N-((3R,4R)-1-ethyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (Tofacitinib Impurity) | C15H23N5 | 2183519-70-0 | Details |
(1S,2S,3R,5S)-3-(7-Chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol (Ticagrelor Impurity) | C14H20ClN5O4S | 2248538-63-6 | Details |
Ethyl 4-(benzofuran-2-yl)-2,4-dioxobutanoate | C14H12O5 | 106276-58-8 | Details |
(2-Bromo-6-fluoro-3-methylphenyl)methanol | C8H8BrFO | 1375069-06-9 | Details |
9-(2-bromopropyl)-9H-purin-6-amine (Tenofovir Impurity) | C8H10BrN5 | 1884329-63-8 | Details |
Ethyl 6-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinate | C14H19BClNO4 | 741709-70-6 | Details |
N-methyl-4-(4-nitrophenoxy)picolinamide (Sorafenib Impurity) | C13H11N3O4 | 864272-34-4 | Details |
N1,N4-bis((R)-1-(3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)succinamide (Trelagliptin Impurity) | C40H42F2N10O6 | 2087874-94-8 | Details |
2-Amino-5-methyl-3-nitrobenzoic acid | C8H8N2O4 | 5465-34-9 | Details |
(2s)-3-Aminopropane-1,2-diol hydrochloride | C3H10ClNO2 | 209849-99-0 | Details |
2-(2-Methyl-1,3-thiazol-4-yl)ethan-1-ol | C6H9NOS | 121357-04-8 | Details |
1-(4,5-Dihydrothiazol-2-yl)azetidin-3-ol (Tebipenem Impurity) | C6H10N2OS | 161715-27-1 | Details |
3,3,3-Trifluoropropane-1-sulfonamide | C3H6F3NO2S | 1033906-44-3 | Details |
1,2-bis(4-fluorophenyl)hydrazine (Cabozantinib Impurity) | C12H10F2N2 | 332-06-9 | Details |
tert-Butyl 3-bromo-2-oxopropanoate | C7H11BrO3 | 16754-73-7 | Details |
((2R,3R,4R)-3-(Benzoyloxy)-4-fluoro-5-hydroxy-4-methyltetrahydrofuran-2-yl)methyl benzoate (Sofosbuvir Impurity) | C20H19FO6 | 1884385-12-9 | Details |
(R)-3-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-3-oxopropyl acrylate (Ibrutinib Impurity) | C28H28N6O4 | 2244619-11-0 | Details |
2-Acetamido-2-methylpropanoic acid | C6H11NO3 | 5362-00-5 | Details |
(8R,9S,13S,14S,17S)-3-Hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl Butyrate (Estradiol Impurity) | C22H30O3 | 18069-79-9 | Details |
Methyl 2,6-dichloro-4-fluorobenzoate | C8H5Cl2FO2 | 232275-56-8 | Details |
4-(2-Methoxyphenyl)butanoic acid | C11H14O3 | 33209-75-5 | Details |
1-(3,5-Dimethylphenyl)cyclopropane-1-carbonitrile | C12H13N | 1154178-67-2 | Details |
2-(((1S,2R,5S)-2-Isopropyl-5-methylcyclohexyl)oxy)acetic acid | C12H22O3 | 94133-41-2 | Details |
Ethyl 6-chloro-2-(2,4-difluorophenyl)pyridine-3-carboxylate | C14H10ClF2NO2 | 745833-19-6 | Details |
methyl 3-amino-4-(2,4,5-trifluorophenyl)butanoate 2-hydroxy-2-phenylacetate (Sitagliptin Impurity) | C19H20F3NO5 | 1253055-94-5 | Details |
N-(3,4-dichlorophenyl)-7-methoxy-6- (3-morpholinopropoxy)quinazolin-4- amine (Gefitinib Impurity) | C22H24Cl2N4O3 | 2089650-13-3 | Details |
3-Bromo-5-(2-methoxyethoxy)pyridine | C8H10BrNO2 | 181585-07-9 | Details |
3-Benzoyl-7-methoxy-2h-chromen-2-one | C17H12O4 | 64267-12-5 | Details |
4-Aminothiane-4-carboxylic acid hydrochloride | C6H12ClNO2S | 67639-41-2 | Details |
methyl phenyl ((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphonate fumarate (Tenofovir Impurity) | C16H20N5O4P | 2126010-02-2 | Details |
4-(hydroxyamino)phenol (Cabozantinib Impurity) | C6H7NO2 | 3505-87-1 | Details |
2-Cyano-5-methyl-2-hexenoic Acid (Pregabalin Impurity) | C8H11NO2 | 869-02-3 | Details |
2-Amino-2-(4-heptylphenethyl)propane-1,3-diol (Fingolimod Impurity) | C18H31NO2 | 745767-97-9 | Details |
2,3-Dibromopropan-1-amine hydrobromide | C3H8Br3N | 6963-32-2 | Details |
sodium (2S,5S)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate (Avibactam Impurity) | C7H12N3NaO6S | 2064219-26-5 | Details |
(4S)-5,5-Dimethyl-2-((5-methyl-3-phenylisoxazole-4-carboxamido)methyl)thiazolidine-4-carboxylic acid (Oxacillin Impurity) | C18H21N3O4S | 1642559-63-4 | Details |
((3R,4R)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methanol (Paroxetine Impurity) | C13H18FNO | 100332-12-5 | Details |
2-(3-Methoxyphenyl)oxirane | C9H10O2 | 32017-77-9 | Details |
2-chlorosuccinic acid (Tofacitinib Impurity) | C4H5ClO4 | 16045-92-4 | Details |
4,6-dichloro-N,N-dimethyl-1,3,5-triazin-2-amine (Vildagliptin Impurity) | C5H6Cl2N4 | 2401-64-1 | Details |
Methyl 2,3-difluoro-4-methylbenzoate | C9H8F2O2 | 773874-06-9 | Details |
(4-(N,N-Diethylsulfamoyl)-2-methylphenyl)boronic acid | C11H18BNO4S | 1217501-54-6 | Details |
1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propan-1-one | C15H21BO3 | 1256359-22-4 | Details |
3-Isopropoxy-4-methoxybenzaldehyde | C11H14O3 | 34123-66-5 | Details |
(6-Bromo-2-fluoro-3-(methoxycarbonyl)phenyl)boronic acid | C8H7BBrFO4 | 957120-79-5 | Details |
3-Bromo-5-chloro-4-methoxybenzaldehyde | C8H6BrClO2 | 161565-36-2 | Details |
(S)-(S)-Quinuclidin-3-yl 1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate (Solifenacin Impurity) | C23H26N2O2 | 732228-02-3 | Details |
(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(pyridin-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate (Abiraterone Impurity) | C24H31NO | 165334-72-5 | Details |
Product Total: Product Page: | ||||
182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 |